Nantahala Capital Management, LLC

Position in IKT — Inhibikase Therapeutics, Inc.

CIK 1472322 New Canaan, CT

Position in IKT

as of Jun 30, 2026 · filed Aug 19, 2026 Compact

Position Value

$5,484,781

+$945,652 QoQ

Shares Held

2,701,863

0.0% QoQ

Ownership

1.94%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#16

of 105 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nantahala Capital Management, LLC holds $620,287,047 across 52 Biotechnology names. IKT ranks #35 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SVRA	Savara Inc	6,976,810	$42,977,149
2	AVTX	Avalo Therapeutics, Inc.	1,862,250	$34,414,380
3	LBRX	Lb Pharmaceuticals Inc	1,052,894	$34,171,674
4	ABEO	Abeona Therapeutics Inc.	5,136,490	$31,743,508
5	ZVRA	Zevra Therapeutics, Inc.	1,797,476	$25,775,805
6	MLYS	Mineralys Therapeutics, Inc.	820,481	$22,136,577
7	QURE	uniQure N.V.	455,660	$20,987,699
8	AURA	Aura Biosciences, Inc.	2,951,030	$20,952,313

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,484,781	2,701,863	0.0%	Shares	Sole	2026-08-19
2026-06-30	$11,795,288	5,810,487	—	Shares	Sole	2026-08-14
2026-03-31	$4,539,129	2,701,863	-31.2%	Shares	Sole	2026-05-15
2025-12-31	$8,055,048	3,929,292	+79.4%	Shares	Sole	2026-02-13
2025-09-30	$3,547,800	2,190,000	0.0%	Shares	Sole	2025-11-14
2025-06-30	$4,270,500	2,190,000	0.0%	Shares	Sole	2025-08-14
2025-03-31	$4,796,100	2,190,000	0.0%	Shares	Sole	2025-05-15
2024-12-31	$7,117,500	2,190,000	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.